• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote

Labiana lifts adjusted EBITDA 10.2% in the first half on revenue of 41.26 million euros

FinanceInternationalAnimalshealth.es35 s readAI summary
Image: Animalshealth.es

Labiana Health, a Spanish pharmaceutical group listed on BME Growth, posted revenue of 41.26 million euros in the first half of 2026, up 5.2%, with adjusted EBITDA of 8.20 million (+10.2%) and adjusted EBIT of 6.19 million (+14.2%). Animal Health drove revenue with a 9.6% rise to 20.77 million. Net profit fell to 0.93 million due to 3.5 million in extraordinary financial expenses tied to the cancellation of the previous financing with Miralta/Blantyre.

In 35 seconds

  • Revenue of 41.26 million euros, up 5.2% from the same period a year earlier.
  • Adjusted EBITDA of 8.20 million (+10.2%) and EBITDA margin of 19.9%, versus 19.0% previously.
  • Animal Health grew 9.6% to 20.77 million and accounted for 50.3% of consolidated revenue.
Read the full story at Animalshealth.es

IASummary generated by artificial intelligence from a story by Animalshealth.es. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading